Recital 37, Regulation (EU) 2021/963

In forcesince 10 Jun 2021

In accordance with Article 109(2) of Regulation (EU) 2019/6, it is also necessary to establish a model form for the information necessary to administer medicinal products included in the list of substances established in accordance with Article 115(5) of that Regulation. At present, the list of substances which are essential for the treatment of equine animals, or which bring added clinical benefit compared to other treatment options available for equine species and for which the withdrawal period for equine species is six months, is laid down in Commission Regulation (EC) No 1950/2006 [Commission Regulation (EC) No 1950/2006 of 13 December 2006 establishing, in accordance with Directive 2001/82/EC of the European Parliament and of the Council on the Community code relating to veterinary medicinal products, a list of substances essential for the treatment of equidae and of substances bringing added clinical benefit (OJ L 367, 22.12.2006, p. 33).].